• Inaccurate Risk Prediction: Existing risk models often miscalculate cardiovascular risks in people with HIV, particularly underestimating them for women and Black individuals in high-income countries and overestimating them in low and middle-income countries.
  • Disparities in Risk Assessment: These discrepancies highlight significant disparities in cardiovascular risk assessment for people with HIV across different demographics and income levels.
  • REPRIEVE Trial Findings: The study analyzed data from the REPRIEVE trial, a large-scale study investigating HIV-related heart disease, to identify these inaccuracies